Aktiesnakken — Marts 2020
-
AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19 https://investor.lilly.com/news-releases/news-release-details/abcellera-and-lilly-co-develop-antibody-therapies-treatment
-
God morgen.
-
Nikkei 225 i Tokyo er ned 2,83 prosent
Hang Seng i Hongkong er ned 1,76 prosent
Kospi i Seoul faller 2,27 prosent
Shanghai Composite er ned én prosent
ASX 200 i Sydney er opp 4,42 prosent -
Recent trial: Sun Shanxian Memorial Hospital, 120 patients, 110 got better with chloroquine, average time till they tested negative 4.4 days, faster than other meds, no significant side effects. Around the time China introduced it to the treatment guidelines (feb 21) their death rate dropped about 4x though unclear if that's the cause. Overall looks good
-
Tak, Henry AS. Klorokin var netop det middel, min egen læge foreslog for uger tilbage, men han blev øjeblikkeligt irettesat af Sundhedsstyrelsen
-
Jazz 07.07 - 4 år for s&p 500. Men det her er jo en anden sitiuation. Men hvis man ligger kontant er man nødt til at gå ind nu hvis man vil med på de næste 4 års optur til S&P rammer 3400 igen. Personligt tror jeg vi er tilbage inderfor 12-18 mdr forudsat vi kommer af med corona inden for de kommende 2-3 mdr eller der kommer en vaccine
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind